Dr. Gönen has been at MSK since 1999 and he has been serving as the Chief of Biostatistics Service since 2015. His translational and clinical collaborations focus on genomic profiling of hematologic malignancies, surgical treatment of gastrointestinal and hepatobiliary cancers and development and evaluation of novel molecular imaging technologies. Most of Dr Gönen’s methodological research originates from these collaborations, including building, assessing and comparing prognostic and predictive models, design and analysis of clinical trials and imaging studies, as well as Bayesian methods. He is a recent awardee of the Foundation for NIH to study alternative response metrics in cancer clinical trials and the author of a book on the use of receiver operating characteristic curves using SAS®.
Dr. Gönen served a co-director of the AACR/ASCO Vail Workshop on Methods in Clinical Cancer Research from 2011 to 2013 and a member of ASCO’s Cancer Research Committee from 2012 to 2014. He has been serving the Society for Clinical Trials in various roles: Program Chair for the 2012 Annual Meeting, deputy editor of Clinical Trials: Journal of the Society for Clinical Trials and member of the board of directors and member of the executive committee. Dr. Gönen is a fellow the American Statistical Association (ASA) and is an associate editor of Statistics in Biopharmaceutical Research, an ASA journal. He served the International Biometric Society as the Program Chair for its North America (ENAR) meeting in 2015.